# A Phase 1 Study of the Absorption, Metabolism, and Excretion of [14C] PBI-200

> **NCT05238337** · PHASE1 · COMPLETED · sponsor: **Pyramid Biosciences** · enrollment: 6 (actual)

## Conditions studied

- Absorption, Metabolism and Excretion in Healthy Volunteers

## Interventions

- **DRUG:** [14C]-PBI-200

## Key facts

- **NCT ID:** NCT05238337
- **Lead sponsor:** Pyramid Biosciences
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-02-24
- **Primary completion:** 2022-03-24
- **Final completion:** 2022-03-24
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2022-08-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05238337

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05238337, "A Phase 1 Study of the Absorption, Metabolism, and Excretion of [14C] PBI-200". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05238337. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*